Intraperitoneal carboplatin in icodextrin 4% as first-line treatment for epithelial ovarian cancer: A phase I/II trial

被引:0
|
作者
Hofman, L.
Sludden, J.
Boddy, A. V.
Murphy, D. J.
Ferry, D. R.
机构
[1] Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands
[2] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[3] New Cross Hosp, Wolverhampton, W Midlands, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5522
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: A phase I trial
    Meerpohl, HG
    duBois, A
    Luck, HJ
    Kuhnle, H
    Mobus, V
    Kreienberg, R
    Bauknecht, T
    Kochli, O
    Bochtler, H
    Diergarten, K
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (01) : S17 - S22
  • [2] A phase II study of carboplatin and doxorubicin as the first-line treatment of ovarian cancer
    Tjuiandin, S.
    Chitia, L.
    Tryakin, A.
    Stenina, M.
    Panichenko, I.
    Zhordania, K.
    Garin, A.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 130 - 130
  • [3] Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
    du Bois, Andreas
    Herrstedt, Jorn
    Hardy-Bessard, Anne-Claire
    Mueller, Hans-Helge
    Harter, Philipp
    Kristensen, Gunnar
    Joly, Florence
    Huober, Jens
    Avall-Lundqvist, Elisabeth
    Weber, Beatrice
    Kurzeder, Christian
    Jelic, Svetislav
    Pujade-Lauraine, Eric
    Burges, Alexander
    Pfisterer, Jacobus
    Gropp, Martina
    Staehle, Anne
    Wimberger, Pauline
    Jackisch, Christian
    Sehouli, Jalid
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4162 - 4169
  • [4] Intraperitoneal chemotherapy as first-line treatment in the management of epithelial ovarian cancer
    Rekhraj, S.
    Kinross, J.
    Prabhudesai, S.
    Darzi, A.
    Ziprin, P.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (05) : 509 - 517
  • [5] Prospective, randomised phase II trial: carboplatin and oral etoposide versus carboplatin and cyclophosphamide in the first-line treatment of ovarian cancer
    Sehouli, J
    Horstkamp, B
    Schonborn, I
    Kettner, H
    Lichtenegger, W
    Noggo
    [J]. 17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1259 - 1263
  • [6] Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
    duBois, A
    Luck, HJ
    Bauknecht, T
    Mobus, V
    Bochtler, H
    Diergarten, K
    Meerpohl, HG
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (04) : 355 - 361
  • [7] Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
    Meier, Werner
    du Bois, Andreas
    Rau, Joern
    Gropp-Meier, Martina
    Baumann, Klaus
    Huober, Jens
    Wollschlaeger, Kerstin
    Kreienberg, Rolf
    Canzler, Ulrich
    Schmalfeldt, Barbara
    Wimberger, Pauline
    Richter, Barbara
    Schroeder, Willibald
    Belau, Antje
    Staehle, Anne
    Burges, Alexander
    Sehouli, Jalid
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 236 - 240
  • [8] Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer
    Fleming, N. D.
    Coleman, R. L.
    Tung, C. S.
    Munsell, M. F.
    Sood, A. K.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 137 : 79 - 79
  • [9] Paclitaxel/carboplatin/gemcitabine as first-line treatment of ovarian cancer
    Hansen, SW
    Geertsen, F
    Stroyer, I
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 96 - 96
  • [10] Phase II trial of high-dose cisplatin plus ifosfamide as first-line followed by carboplatin as second-line treatment in epithelial ovarian carcinoma
    Strauss, G
    Lund, B
    Hansen, M
    Hansen, HH
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 66 (01) : 66 - 70